Evidence map›Paper›PMID 34251522›Full record

ArticleClinical and experimental nephrology2021

Nationwide questionnaire survey on the management of chronic kidney disease for general practitioners in Japan.

Satoru Tatematsu, Kazuo Kobayashi, Yasunori Utsunomiya, Taisuke Isozaki, Tsuguru Hatta, Takuo Kusumoto, Masanobu Miyazaki, Nobuo Hatori, Haruhisa Otani

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Satoru TatematsuCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Kazuo KobayashiCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan. k-taishi@xc4.so-net.ne.jp.ORCID http://orcid.org/0000-0002-1284-9728
Yasunori UtsunomiyaCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Taisuke IsozakiCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Tsuguru HattaCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Takuo KusumotoCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Masanobu MiyazakiCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Nobuo HatoriKobayashi Hospital, Kanagawa, Japan.
Haruhisa OtaniCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo, Japan.
Japan Medical Association · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2019, a nationwide questionnaire survey on the management of chronic kidney disease (CKD) was circulated to general practitioners (GPs) throughout Japan by The Japan Physicians Association. The aim was to assess the current state of CKD medical care in the country and evaluate the utilization of CKD-specific guidelines in the treatment by GPs.

methodsThe voluntary survey targeted all members of Japan Physicians Association, a nationwide organization consisting primarily of 15,000 GPs in clinics throughout the country. GPs were divided into groups: 171 GPs using and 414 GPs not using the guidelines. Comparisons between the groups' responses were made using propensity score matching and component cluster analysis.

resultsOverall responses revealed that the estimated glomerular filtration rate's utilization rate was high (95.1%). However, evidence-practice gaps in urine protein quantification and anemia remedy were prominent. There were significantly favorable answers in terms of CKD management in the user group compared with those in the non-user group, except for the questions about a urine check at the first visit, stopping the use of renin-angiotensin system inhibitors, and the target blood pressure for elderly CKD patients. The differences suggest that utilization of the CKD guidelines has improved CKD management practices by GPs.

conclusionsFurther promotion of CKD guidelines utilization (28% in this survey) is considered valid for CKD medical education.

Indexed as

AdultAgedAnemiaGeneral PractitionersGlomerular Filtration RateGuideline AdherenceHealth Care SurveysHematinicsHemoglobinsHumansJapanMiddle AgedPractice Guidelines as TopicPractice Patterns, Physicians'ProteinuriaRenal Insufficiency, ChronicHematinicsHemoglobinsChronic kidney diseaseGeneral practitionersGuidelinesQuestionnaire survey

Identifiers

PMID34251522
OpenAlexW3179244651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.